Historical record - last NADAC effective date: 6/21/2023
Product Information
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2135 per ML under NDC 43386016901. Its NADAC has been published 233 times since Mar 13, 2019.
FDA first approved this application on Aug 29, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
40 meq/15mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386016901
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
6/21/2023
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209786FDA Approved
8/29/2018
TE Code
AA
On Market Since
9/24/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 233 times since Mar 13, 2019, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2135 per ML |
|---|---|
| All-time high | $0.7302 (May 15, 2019) |
| All-time low | $0.0653 (Dec 21, 2022) |
| Median price | $0.5184 |
| Average price | $0.4783 |
| Largest weekly change | +163.0% (Jan 18, 2023) |
| Weeks tracked | 233 |
| Tracking since | Mar 13, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
-69.8%
All
-70.3%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by Lupin Pharmaceuticals Inc., is $0.2135 per ML (NDC 43386016901), effective Aug 23, 2023.
How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has declined 70.3%. It has been tracked across 233 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
Since Mar 13, 2019, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0653 (Dec 21, 2022) to a high of $0.7302 (May 15, 2019), with a median of $0.5184 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, is $0.0778 per ML — about 64% below POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID.
Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 43386016901) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.